These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 24295148)
21. Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures. Cracolici V; Mujacic I; Kadri S; Alikhan M; Niu N; Segal JP; Rosen LE; Sarne DH; Morgan A; Desouky S; Cipriani NA Endocr Pathol; 2018 Mar; 29(1):9-14. PubMed ID: 28710706 [TBL] [Abstract][Full Text] [Related]
22. Glycolysis-related protein expression in thyroid cancer. Nahm JH; Kim HM; Koo JS Tumour Biol; 2017 Mar; 39(3):1010428317695922. PubMed ID: 28347233 [TBL] [Abstract][Full Text] [Related]
23. Expression of the embryonic morphogen Nodal in differentiated thyroid carcinomas: Immunohistochemistry assay in tissue microarray and The Cancer Genome Atlas data analysis. Chai YJ; Kim YA; Jee HG; Yi JW; Jang BG; Lee KE; Park YJ; Youn YK Surgery; 2014 Dec; 156(6):1559-67; discussion 1567-8. PubMed ID: 25456955 [TBL] [Abstract][Full Text] [Related]
25. Diagnosis and management of differentiated thyroid cancer using molecular biology. Witt RL; Ferris RL; Pribitkin EA; Sherman SI; Steward DL; Nikiforov YE Laryngoscope; 2013 Apr; 123(4):1059-64. PubMed ID: 23404751 [TBL] [Abstract][Full Text] [Related]
26. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features. Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472 [TBL] [Abstract][Full Text] [Related]
27. Improvement of the cytological diagnostic accuracy of follicular thyroid lesions by the use of the Ki-67 proliferative index in addition to cytokeratin-19 and HBME-1 immunomarkers: a study of 61 cases of liquid-based FNA cytology with histological controls. Lacoste-Collin L; d'Aure D; Bérard E; Rouquette I; Delisle MB; Courtade-Saïdi M Cytopathology; 2014 Jun; 25(3):160-9. PubMed ID: 24460983 [TBL] [Abstract][Full Text] [Related]
28. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma. Zhao L; Dias-Santagata D; Sadow PM; Faquin WC Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645 [TBL] [Abstract][Full Text] [Related]
29. RE: HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer. Simeone P; Alberti S J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27418631 [No Abstract] [Full Text] [Related]
30. The pathologist's role in familial nonmedullary thyroid tumors. Cameselle-Teijeiro J Int J Surg Pathol; 2010 Jun; 18(3 Suppl):194S-200S. PubMed ID: 20484290 [No Abstract] [Full Text] [Related]
31. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer. Trovato M; Fraggetta F; Villari D; Batolo D; Mackey K; Trimarchi F; Benvenga S J Clin Endocrinol Metab; 1999 Sep; 84(9):3235-40. PubMed ID: 10487693 [TBL] [Abstract][Full Text] [Related]
32. Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma. Salajegheh A; Pakneshan S; Rahman A; Dolan-Evans E; Zhang S; Kwong E; Gopalan V; Lo CY; Smith RA; Lam AK Hum Pathol; 2013 Oct; 44(10):2204-12. PubMed ID: 23845470 [TBL] [Abstract][Full Text] [Related]
34. [Loss of heterozygosity on chromosome 3p in thyroid tumors]. Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647 [TBL] [Abstract][Full Text] [Related]
35. Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma. Kim TH; Lee M; Kwon AY; Choe JH; Kim JH; Kim JS; Hahn SY; Shin JH; Chung MK; Son YI; Ki CS; Yim HS; Kim YL; Chung JH; Kim SW; Oh YL Histopathology; 2018 Mar; 72(4):648-661. PubMed ID: 28940583 [TBL] [Abstract][Full Text] [Related]
36. Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes. Celestino R; Sigstad E; Løvf M; Thomassen GO; Grøholt KK; Jørgensen LH; Berner A; Castro P; Lothe RA; Bjøro T; Sobrinho-Simões M; Soares P; Skotheim RI Genes Chromosomes Cancer; 2012 Dec; 51(12):1154-64. PubMed ID: 22961909 [TBL] [Abstract][Full Text] [Related]
37. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Dahia PL; Marsh DJ; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C Cancer Res; 1997 Nov; 57(21):4710-3. PubMed ID: 9354427 [TBL] [Abstract][Full Text] [Related]
38. [Molecular basis of tumors arising in thyroid follicular cells]. Wynford-Thomas D Ann Chir; 1999; 53(3):237-43. PubMed ID: 10339867 [TBL] [Abstract][Full Text] [Related]
39. Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial nonmedullary thyroid carcinoma Italian families. Cirello V; Colombo C; Persani L; Fugazzola L Int J Cancer; 2019 Jul; 145(2):600. PubMed ID: 30828786 [No Abstract] [Full Text] [Related]
40. Mitochondrial DNA alterations in thyroid cancer. Tong BC; Ha PK; Dhir K; Xing M; Westra WH; Sidransky D; Califano JA J Surg Oncol; 2003 Mar; 82(3):170-3. PubMed ID: 12619060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]